Literature DB >> 25367017

Arthroscopic acetabuloplasty and labral refixation without labral detachment.

John M Redmond1, Youssef F El Bitar1, Asheesh Gupta1, Christine E Stake1, S Pavan Vemula, Benjamin G Domb2.   

Abstract

BACKGROUND: Arthroscopic acetabuloplasty was initially described with detachment of the labrum to access the acetabular rim for resection, followed by labral refixation. Recent technical improvements have made it possible to perform acetabuloplasty and labral refixation without labral detachment when the chondrolabral junction is intact.
PURPOSE: To compare outcomes for patients undergoing arthroscopic acetabuloplasty and labral refixation without labral detachment (study group), as well as compare this with a group of patients who underwent acetabuloplasty with labral refixation and labral detachment (control group) with a minimum 2-year follow-up. STUDY
DESIGN: Cohort study; Level of evidence, 3.
METHODS: During the study period, data were prospectively collected on all patients treated with hip arthroscopy. Inclusion criteria for the study group were acetabuloplasty and labral refixation without detachment, performed in cases with an intact chondrolabral junction. Patients were then compared with a control group of patients who had acetabuloplasty with labral detachment and refixation. All patients were assessed pre- and postoperatively using 4 patient-reported outcome (PRO) measures and a visual analog scale (VAS) for pain, as well as monitored for revision surgery.
RESULTS: In the study group, the preoperative to postoperative score changed from 64.2 to 86.6 for modified Harris Hip Score (mHHS), 60.5 to 83.8 for Nonarthritic Hip Score (NAHS), 65.3 to 87.3 for Hip Outcome Score-Activity of Daily Living (HOS-ADL), 45 to 75.1 for Hip Outcome Score-Sport-Specific Subscale (HOS-SSS), and 5.7 to 2.6 for VAS. In the control group, the preoperative to postoperative score changed from 61.2 to 84.4 for mHHS, 59 to 84 for NAHS, 62.7 to 86.2 for HOS-ADL, 40.1 to 74.1 for HOS-SSS, and 6.3 to 2.8 for VAS. There was no difference between preoperative and postoperative PRO scores. The preoperative VAS score was lower in the study group than in the control group (P=.04). The control group demonstrated larger mean preoperative anterior center edge angles (ACEA) (33.8° vs 29.5°) and mean alpha angles (60.5° vs 53.5°) than the study group (P<.05). There was no statistically significant difference in the change in PRO or VAS scores between groups. Both groups demonstrated significant improvement from preoperative to 2-year follow-up for all 4 PRO scores (P<.05) and decrease in VAS (P<.05). One patient in the study group converted to total hip arthroplasty. Seven patients underwent revision hip arthroscopy in the study group, and 8 patients in the control group underwent revision hip arthroscopy. There was no difference in revision rates between groups.
CONCLUSION: Treatment of pincer- and combined-type impingement with arthroscopic acetabuloplasty and labral refixation without detachment, when possible, resulted in similar patient outcomes compared with acetabuloplasty with labral detachment. We may conclude that in cases where the chondrolabral junction remains intact, acetabuloplasty and labral refixation without detachment is a viable option.
© 2014 The Author(s).

Entities:  

Keywords:  acetabuloplasty; femoroacetabular impingement; hip arthroscopy; hip labrum; labral detachment; labral refixation; labral repair; labral takedown; pincer impingement

Mesh:

Year:  2014        PMID: 25367017     DOI: 10.1177/0363546514555330

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  20 in total

1.  The clinical outcome of chondrolabral-preserving arthroscopic acetabuloplasty for pincer- or mixed-type femoroacetabular impingement: A systematic review.

Authors:  M-A Malahias; M M Alexiades
Journal:  Musculoskelet Surg       Date:  2019-03-08

2.  What Are the Risk Factors for Revision Surgery After Hip Arthroscopy for Femoroacetabular Impingement at 7-year Followup?

Authors:  Pascal Cyrill Haefeli; Christoph Emanuel Albers; Simon Damian Steppacher; Moritz Tannast; Lorenz Büchler
Journal:  Clin Orthop Relat Res       Date:  2017-04       Impact factor: 4.176

3.  Anatomic Labral Repair in the Hip Using a Knotless Tensionable Suture Anchor.

Authors:  Carlos Suarez-Ahedo; Timothy J Martin; John P Walsh; Sivashankar Chandrasekaran; Parth Lodhia; Benjamin G Domb
Journal:  Arthrosc Tech       Date:  2016-09-26

Review 4.  New perspectives on femoroacetabular impingement syndrome.

Authors:  Moin Khan; Asheesh Bedi; Freddie Fu; Jon Karlsson; Olufemi R Ayeni; Mohit Bhandari
Journal:  Nat Rev Rheumatol       Date:  2016-03-10       Impact factor: 20.543

Review 5.  Hip labral repair: options and outcomes.

Authors:  Joshua D Harris
Journal:  Curr Rev Musculoskelet Med       Date:  2016-12

6.  FUNCTIONAL OUTCOMES OF HIP ARTHROSCOPY IN AN ACTIVE DUTY MILITARY POPULATION UTILIZING A CRITERION-BASED EARLY WEIGHT BEARING PROGRESSION.

Authors:  K Aaron Shaw; Jeremy M Jacobs; J Richard Evanson; Josh Pniewski; Michelle L Dickston; Terry Mueller; John A Bojescul
Journal:  Int J Sports Phys Ther       Date:  2017-10

Review 7.  Open and Arthroscopic Surgical Treatment of Femoroacetabular Impingement.

Authors:  Benjamin D Kuhns; Rachel M Frank; Luis Pulido
Journal:  Front Surg       Date:  2015-12-02

8.  Labral cuff refixation in the hip: rationale and operative technique for preserving the chondrolabral interface for labral repair: a case series.

Authors:  Patrick Finton Carton; David Filan
Journal:  J Hip Preserv Surg       Date:  2017-10-10

Review 9.  The current situation in hip arthroscopy.

Authors:  Oliver Marin-Peña; Marc Tey-Pons; Luis Perez-Carro; Hatem G Said; Pablo Sierra; Pedro Dantas; Richard N Villar
Journal:  EFORT Open Rev       Date:  2017-04-27

10.  "In-Round" Labral Repair After Acetabular Recession Using Intermittent Traction.

Authors:  Nathan W Skelley; William K Conaway; Scott D Martin
Journal:  Arthrosc Tech       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.